FDA NDC Directory · JSON-LD · Markdown

Bromocriptine mesylate

NDC 0574-0106 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerPadagis US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA077646
Dosage form / routeTABLET · ORAL
Active ingredientsBROMOCRIPTINE MESYLATE (2.5 mg/1)
Marketing started20140401
Package count2

External sources

Source: openFDA. Public-domain (CC0).